Cargando…
Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
Introduction: Pharmacogenetics (PGx) has the potential to improve health outcomes but cost of testing is a barrier for equitable access. Reimbursement by insurance providers may lessen the financial burden for patients, but the extent to which PGx claims are covered in clinical practice has not been...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461057/ https://www.ncbi.nlm.nih.gov/pubmed/37645439 http://dx.doi.org/10.3389/fphar.2023.1179364 |